NCT01063348View on ClinicalTrials.gov

N-Acetyl Cysteine in Pathologic Skin Picking

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Pathologic Skin PickingNeurotic ExcoriationPsychogenic ExcoriationDermatillomania
Interventions
DRUG

N-Acetyl Cysteine

Week 0 (Visit 1) - Week 3 (V2): 1200mg/day (600mg po qam and 600mg po qpm) Week 3 (V2) - Week 6 (V3): 2400mg/day (1200mg po qam and 1200mg po qpm) Week 6 (V4) - Week 12 (V5): 3000mg/day (1200mg po qam and 1800mg po qpm)

DRUG

Placebo

Matching placebo capsules taken in same amount of pills as the active medication.

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT01063348 - N-Acetyl Cysteine in Pathologic Skin Picking | Biotech Hunter | Biotech Hunter